SCNX (Scienture Holdings, Inc. Common Stock) Stock Analysis - Financials

Scienture Holdings, Inc. Common Stock (SCNX) is a publicly traded Healthcare sector company. As of May 21, 2026, SCNX trades at $0.39 with a market cap of $15.99M and a P/E ratio of -0.14. SCNX moved -2.15% today. Year to date, SCNX is -25.14%; over the trailing twelve months it is -57.40%. Its 52-week range spans $0.24 to $9.55. Analyst consensus is buy with an average price target of $1.50. Rallies surfaces SCNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SCNX's key financials?

SCNX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SCNX recently traded at $0.39. Market cap is $15.99M. P/E ratio is -0.14. Revenue is $431.61K.

SCNX Key Metrics

Key financial metrics for SCNX
MetricValue
Price$0.39
Market Cap$15.99M
P/E Ratio-0.14
EPS$-2.70
Dividend Yield0.00%
52-Week High$9.55
52-Week Low$0.24
Volume6.76K
Avg Volume0
Revenue (TTM)$431.61K
Net Income$-41.51M
Gross Margin76.80%

SCNX Annual Financials

YearRevenueNet IncomeEPS
2025$431.61K$-41.51M$-2.70
2024$136.64K$9.07M$2.69

Latest SCNX News

SCNX Analyst Consensus

1 analysts cover SCNX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.50.

Common questions about SCNX

What are SCNX's key financials?
SCNX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SCNX recently traded at $0.39. Market cap is $15.99M. P/E ratio is -0.14. Revenue is $431.61K.
Is SCNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SCNX. It does not provide personalized investment advice.
SCNX

SCNX